Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway [Corrigendum]
Mu M, Zuo S, Wu RM, et al. Drug Des Devel Ther. 2018;12:4107–4115. An error has been found in a couple of the image labels for Figure 3F. On page 4112, the original Figure 3F image appears as: Read the original article:
Main Authors: | Mu M, Zuo S, Wu RM, Deng KS, Lu S, Zhu JJ, Zou GL, Yang J, Cheng ML, Zhao XK |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-05-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | https://www.dovepress.com/corrigendum-ferulic-acid-attenuates-liver-fibrosis-and-peer-reviewed-article-DDDT |
Similar Items
-
Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway
by: Mu M, et al.
Published: (2018-12-01) -
Dissection of TGF-beta/Smads in the renal inflammation and fibrosis.
Published: (2012) -
Astragaloside IV Synergizing with Ferulic Acid Ameliorates Pulmonary Fibrosis by TGF-β1/Smad3 Signaling
by: Jiahuan Tong, et al.
Published: (2021-01-01) -
Ferulic Acid Attenuates TGF-β1-Induced Renal Cellular Fibrosis in NRK-52E Cells by Inhibiting Smad/ILK/Snail Pathway
by: Ming-gang Wei, et al.
Published: (2015-01-01) -
Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer
by: Carmine Stolfi, et al.
Published: (2021-12-01)